Motor Neurone Disease Trial, Recruiting NCT06051123 Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT06051123
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have ALS (with or without frontotemporal dementia symptoms):

  • You are 18 years of age or older
  • You have been diagnosed with ALS using a standard set of medical criteria
  • Your muscle weakness or speech problems began no more than 24 months before joining the study
  • Your ALS functioning score and breathing capacity are above certain minimum levels at your initial screening (confirm with trial site)
  • You have a caregiver or close contact who knows you well enough to answer questions about your thinking and behaviour
  • You are able to understand and sign a consent form
  • If you could become pregnant, you have a negative pregnancy test at screening and agree to use an approved form of birth control throughout the study (including abstinence, hormonal contraceptives, double-barrier methods, intrauterine devices, or a partner who has had a vasectomy for at least 6 months)
  • You are willing to keep your eating habits the same throughout the study
  • You are willing to stop taking probiotic supplements and avoid foods with added probiotics or prebiotics (such as yogurts with live cultures) from screening until the end of the study

If you are a healthy volunteer:

  • You are 18 years of age or older
  • You are able to understand and willing to sign a consent form
  • If you could become pregnant, you have a negative pregnancy test at screening and agree to use an approved form of birth control throughout the study
  • You are willing to keep your eating habits the same throughout the study
  • You are willing to avoid probiotic supplements and foods with added probiotics or prebiotics from the start of the study until it ends

If you are a caregiver or informant:

  • You are 18 years of age or older
  • You have regular and close enough contact with the patient to accurately describe their thinking abilities and behaviour
  • You are able to understand and willing to sign a consent form

Who may not be able to join:

If you have ALS:

  • You are currently using a breathing machine or breathing support device
  • You have a serious medical condition or behavioural issue that the study doctor believes could interfere with your participation
  • You are currently using a feeding tube
  • You have been taking cholesterol-lowering medication for less than 3 months before joining, or you recently started one (unless it was prescribed due to a heart attack or stroke)
  • You have been taking the ALS medication edaravone at a stable dose for less than 2 months, or riluzole at a stable dose for less than 1 month before joining
  • You start taking edaravone or riluzole during the trial
  • You have a weakened immune system (for example, due to HIV/AIDS, lymphoma, long-term steroid use, chemotherapy, or an organ transplant)
  • You are currently pregnant, planning to become pregnant, or breastfeeding
  • You have taken probiotic supplements in the month before joining (though you may be eligible after a 4-week break)
  • You have taken antibiotics in the month before joining (though you may be eligible after a 4-week break)
  • You have a milk or soy allergy, or severe lactose intolerance
  • You are currently taking part in another clinical trial

If you are a healthy volunteer:

  • You have been taking cholesterol-lowering medication for less than 3 months, or recently started one (unless due to a heart attack or stroke)
  • You are currently pregnant, planning to become pregnant, or breastfeeding
  • You have taken probiotic supplements in the month before the study starts (though you may be eligible after a 4-week break)
  • You have taken antibiotics in the month before the study starts (though you may be eligible after a 4-week break)
  • You have a milk or soy allergy, or severe lactose intolerance
  • You are currently taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Genevieve Matte, MDCM, FRCP, CRCHUM

Phone: 514-890-8000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 February 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in lipids and polar metabolites composition in the plasma of participant

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov